BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17457033)

  • 1. Nongenetic model of type 2 diabetes: a comparative study.
    Islam MS; Choi H
    Pharmacology; 2007; 79(4):243-9. PubMed ID: 17457033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
    Reed MJ; Meszaros K; Entes LJ; Claypool MD; Pinkett JG; Gadbois TM; Reaven GM
    Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.
    Sugano M; Yamato H; Hayashi T; Ochiai H; Kakuchi J; Goto S; Nishijima F; Iino N; Kazama JJ; Takeuchi T; Mokuda O; Ishikawa T; Okazaki R
    Nutr Metab Cardiovasc Dis; 2006 Oct; 16(7):477-84. PubMed ID: 17015185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the duration of high-fat diet and the dosage of streptozotocin on establishing experimental animal model of type 2 diabetes mellitus].
    Wang B; Li Y; Liu X; Liu S; Sun C
    Wei Sheng Yan Jiu; 2011 Jan; 40(1):99-102, 106. PubMed ID: 21434325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
    Sahin K; Onderci M; Tuzcu M; Ustundag B; Cikim G; Ozercan IH; Sriramoju V; Juturu V; Komorowski JR
    Metabolism; 2007 Sep; 56(9):1233-40. PubMed ID: 17697867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
    Srinivasan K; Viswanad B; Asrat L; Kaul CL; Ramarao P
    Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium].
    Wen ZY; Wu Y; Li Y; Chen XL; Wang T; Ouyang JP; Li GS
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1460-3. PubMed ID: 16061022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the intervening mechanism of taurine on streptozotocin-induced diabetic cataracts].
    Song XD; Chen CZ; Dong B; Shi YY; Zhang W; Yan LS; Luo GA
    Zhonghua Yan Ke Za Zhi; 2003 Oct; 39(10):605-9. PubMed ID: 14766075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Dosage of streptozocin in inducing rat model of type 2 diabetes mellitus].
    Xiang X; Wang Z; Zhu Y; Bian L; Yang Y
    Wei Sheng Yan Jiu; 2010 Mar; 39(2):138-42. PubMed ID: 20459021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of a rat model of type II diabetic neuropathic pain.
    Dang JK; Wu Y; Cao H; Meng B; Huang CC; Chen G; Li J; Song XJ; Lian QQ
    Pain Med; 2014 Apr; 15(4):637-46. PubMed ID: 24716590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose streptozotocin (STZ) combined with high energy intake can effectively induce type 2 diabetes through altering the related gene expression.
    Wang HJ; Jin YX; Shen W; Neng J; Wu T; Li YJ; Fu ZW
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():412-7. PubMed ID: 17392141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exacerbation of poststroke dementia by type 2 diabetes is associated with synergistic increases of beta-secretase activation and beta-amyloid generation in rat brains.
    Zhang T; Pan BS; Zhao B; Zhang LM; Huang YL; Sun FY
    Neuroscience; 2009 Jul; 161(4):1045-56. PubMed ID: 19376202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular injection of soluble receptor for advanced glycation endproducts expression vector prevents the development of streptozotocin-induced diabetes mellitus in rats on high fat diet.
    Su X; Meng X; Sun C; Liu L; Su B
    J Diabetes; 2011 Dec; 3(4):309-16. PubMed ID: 21883977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of a type 2 maternal diabetes rodent model using the combination of high-fat diet and moderate dose of streptozocin.
    Gutierrez JC; Bahamonde J; Prater MR; Yefi CP; Holladay SD
    Endocr Res; 2010 May; 35(2):59-70. PubMed ID: 20408754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicotinamide on prevention and treatment of streptozotocin-induced diabetes mellitus in rats.
    Hu Y; Wang Y; Wang L; Zhang H; Zhang H; Zhao B; Zhang A; Li Y
    Chin Med J (Engl); 1996 Nov; 109(11):819-22. PubMed ID: 9275363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nicotinamide on experimental induced diabetes.
    Alenzi FQ
    Iran J Allergy Asthma Immunol; 2009 Mar; 8(1):11-8. PubMed ID: 19279354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Establishment of a rat model of diabetic erectile dysfunction].
    Cheng Y; Wei AY; Li YG
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Apr; 28(4):564-6. PubMed ID: 18495591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes.
    Chao PC; Li Y; Chang CH; Shieh JP; Cheng JT; Cheng KC
    Biomed Pharmacother; 2018 May; 101():155-161. PubMed ID: 29486333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of glycogen in the placenta and fetal and maternal livers of cadmium-exposed diabetic pregnant rats.
    Yoruk M; Kanter M; Meral I; Agaoglu Z
    Biol Trace Elem Res; 2003; 96(1-3):217-26. PubMed ID: 14716101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in DPP-IV in the intestine, liver and kidney of the rat treated with high fat diet and streptozotocin.
    Yang J; Campitelli J; Hu G; Lin Y; Luo J; Xue C
    Life Sci; 2007 Jul; 81(4):272-9. PubMed ID: 17583752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.